🧵1/3 #IDtwitter first trivia of 2023!#TxID

45 F w/Hx of hypertensive nephropathy complicated by ESDR s/p kidney transplant 7 mo ago, on tacrolimus & MMF. CMV D+R-, who after completing prophylaxis w/ valganciclovir for 6mo is admitted with 3 wks of watery diarrhea
2/3 Colonoscopy findings consistent with CMV colitis. Initial CMV DNAemia 800 IU/mL. Patient’s immunosuppressive regimen is reduced, and she is treated with ganciclovir 5 mg/kg IV every 12 hours.
3/3 After one week, despite medical treatment diarrhea persists, with up to 6-8 episodes daily.

A repeated CMV DNAemia is 805 IU/mL. What would you do next? 🤔 #IDboardreview
🪡 1/4 #IDTwitter
Answer: A) Continue with the same therapy

-Refractory CMV disease progresses despite antiviral agents and reduction of immunosuppression and can be due to ganciclovir resistance😷
2/4
-Ganciclovir resistance should be suspected in patients who have rising or persistently elevated viral loads despite treatment with appropriately dosed ganciclovir for more than two weeks 🗓️
3/4
-It occurs in 1 to 2% of kidney transplant recipients with CMV infection or disease and typically develops in CMV D+/R- patients
 
Genotype testing should be performed to identify specific resistance mutations 🧪
4/5
-Thank you everyone for participating! And thanks to @KottonNelson for this amazing material.

link.springer.com/referenceworke…

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with The Infectious Diseases Trivia

The Infectious Diseases Trivia Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @TheIDtrivia

Jul 16, 2022
🧵 #IDtwitter , the #ImagesinID files bring us this tongue lesion 🔍 🗂 #IdBoardReview #MedTwitter

44 year old male, HIV (+), non adherent to antiretroviral therapy (CD4 120) presents for evaluation of this lesion: Image credits: Academia Esp...
🤔 The most likely microorganism responsible for this finding is:
🪡1/5 B) Treponema Pallidum

This patient presents with a syphilitic gumma in the setting of tertiary syphilis

Although gummatous disease is uncommon, HIV patients have an increased risk of developing gummas most frequently in the oral cavity, skin or a viscera.
Read 7 tweets
Feb 26, 2022
🧵 1/5 Hello #IDtwitter. Here is our weekly #IDtrivia 📖 #IDboardreview #TxID #MedEd

37 y/o F PMHx of lupus nephritis complicated by ESRD s/p living-donor kidney transplant 5 months ago, who presents with 3 days Hx of dysuria, hematuria, pelvic pain and subjective fever
2/5 She denies recent lupus flares. Patient is taking tacrolimus, mycophenolate, prednisone and TMP-SMX. Vaccinated against COVID-19x3. No sexually active for the past year. PreTransplant HIV,CMV,HepBC, adenovirus, Toxo and trypanosoma serologies (-) for both patient and donor.
3/5 On presentation BP 140/90 HR 78 RR 16 T 101 O2Sat98% RA. Hydrated mucous membranes. Clear chest to auscultation, normal heart sounds. Abdominal scar healed no signs of infection. Tenderness to palpation of hypogastrium. No CVA tendernesses.
Read 5 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us on Twitter!

:(